Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Urban, C; Benesch, M; Sovinz, P; Schwinger, W; Lackner, H.
Fatal Evans' syndrome after matched unrelated donor transplantation for hyper-IgM syndrome.
EUR J HAEMATOL. 2004; 72(6): 444-447. Doi: 10.1111/j.1600-0609.2004.00256.x (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Führende Autor*innen der Med Uni Graz
Benesch Martin
Urban Ernst-Christian
Co-Autor*innen der Med Uni Graz
Lackner Herwig
Ritter-Sovinz Petra
Schwinger Wolfgang
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
A 3 and 1/2-yr-old boy underwent matched unrelated stem cell transplantation (SCT) for hyper-IgM syndrome. He developed acute and chronic skin graft-vs.-host disease (GVHD). Ten months following SCT he presented with severe hemolytic anemia and thrombocytopenia (Evans' syndrome). Treatment included high-dose steroids, intravenous immunoglobulins, cyclosporine, mycophenolate mofetil, chemotherapeutic agents (cyclophosphamide, vincristine, VP-16), immunoadsorption, and anti-CD20 and anti-CD52 monoclonal antibodies without response. The patient died 16 months after SCT.
Find related publications in this database (using NLM MeSH Indexing)
Anemia, Hemolytic, Autoimmune - drug therapy
Blood Donors - drug therapy
Fatal Outcome - drug therapy
Graft vs Host Disease - etiology
Hematopoietic Stem Cell Transplantation - adverse effects
Humans - adverse effects
Immunoglobulin M - adverse effects
Immunologic Deficiency Syndromes - complications
Immunosuppressive Agents - therapeutic use
Infant - therapeutic use
Male - therapeutic use
Skin Diseases - etiology
Syndrome - etiology
Thrombocytopenia - drug therapy
Treatment Failure - drug therapy

Find related publications in this database (Keywords)
Evans' syndrome
hyper-IgM syndrome
stem cell transplantation
© Med Uni Graz Impressum